Abstract
To define which mycobacterial antigens were responsible for the activation of synovial fluid T lymphocytes, acetone-precipitated Mycobacterium tuberculosis (AP-MT) antigens were separated into five fractions following polyacrylamide gel electrophoresis and added to the mononuclear cell cultures of patients with inflammatory synovitis. Fractions 2 (50 to 70 kDa) and 5 (< 28 kDa) resulted in significantly more proliferation than that of fractions 1, 3, and 4. The response to a purified mycobacterial 65-kDa heat shock protein (hsp), which migrated in fraction 2, was highly correlated (r = 0.89, P < 0.001) with the response to the crude AP-MT. The proliferative response to a different hsp, the Escherichia coli DnaK, by synovial fluid lymphocytes was marginal. Analysis of the synovial fluid T cell response to mycobacterial culture filtrates by T cell Western blotting revealed dominant responses to antigen(s) in the range of 31 to 21 kDa in each responding patient, although no other consistent pattern of T cell activation was noted. Three lines of evidence suggested that the response to the low molecular weight fractions was directed against degradation fragments of the 65-kDa protein. These observations suggest that the activation of T lymphocytes obtained from inflammatory synovial fluids by crude mycobacterial antigens was due in large part to recognition of the 65-kDa mycobacterial hsp.
Original language | English (US) |
---|---|
Pages (from-to) | 95-108 |
Number of pages | 14 |
Journal | Cellular Immunology |
Volume | 133 |
Issue number | 1 |
DOIs | |
State | Published - Mar 1991 |
Funding
We thank the World Health Organization and Dr. T. M. Shinnick, C.D.C. (Atlanta, GA) for providing some of the monoclonal and the polyclonal anti-65-kDa antibodies used in this study. We thank Mr. Rick Jasman for his help in preparing the monoclonal antibodies and Dr. James Sinecore for his expert assistance with the statistical analyses. We also thank our colleagues R. Chang, S. Isley, A. Koch, P. Macius, F. Schmid, J. Schroeder, and L. Sharma for allowing us to study their patients. This research was supported by NIH, Multipurpose Arthritis Center Grant (PO AM 30692), the VA Research Service and the Illinois Chapter of the Arthritis Foundation, NIH AI 23982 (TMB), and Grant RF 86063 from the Rockefeller Foundation (TMB).
ASJC Scopus subject areas
- Immunology